Preparation and evaluation of oleoyl-carboxymethy-chitosan (OCMCS) nanoparticles as oral protein carriers

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 2, 2012, Pages 375-384

  Liu, Ya ^a   Cheng, Xiao Jie ^a   Dang, Qi Feng ^a   Ma, Fang Kui ^a   Chen, Xi Guang ^a   Park, Hyun Jin ^b   Kim, Bum Keun ^c  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b Korea University   (South Korea)

^c Korea Food Research Institute   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AEROMONAS HYDROPHILA; AMPHIPHILICS; CYPRINUS CARPIO; EXTRACELLULAR; IN-CONTROL; INTESTINAL MUCOSA; MEAN DIAMETER; MODIFIED CHITOSAN; ORAL ADMINISTRATION; POSITIVE SURFACE CHARGE; PROTEIN CARRIER; PROTEIN DRUGS; SELF-ASSEMBLED; SPHERICAL SHAPE; SUSTAINED RELEASE;

ANTIGENS; CHITOSAN; DRUG PRODUCTS; IMMUNIZATION;

NANOPARTICLES;

CHITOSAN DERIVATIVE; DRUG CARRIER; FLUORESCEIN ISOTHIOCYANATE; NANOPARTICLE; OLEOYLCARBOXYMETHY CHITOSAN; UNCLASSIFIED DRUG;

AEROMONAS HYDROPHILA; ANIMAL EXPERIMENT; ARTICLE; CARP; FLUORESCENCE MICROSCOPY; HEART; IN VIVO STUDY; INTESTINE; INTESTINE MUCOSA; LIGHT SCATTERING; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, ORAL; AEROMONAS; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIGENS; BIOCOMPATIBLE MATERIALS; CARPS; CHITOSAN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; LIGHT; MATERIALS TESTING; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR WEIGHT; NANOPARTICLES; NANOTECHNOLOGY; SOLUBILITY; STRESS, MECHANICAL; WATER;

AEROMONAS HYDROPHILA; CYPRINIDAE; CYPRINUS CARPIO;

EID: 84861096141     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-011-4470-9     Document Type: Article

References (35)

1. Radwan MA, Aboul-Enein HY. The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly (ethylcyanoacrylate) nanospheres in diabetic rats. J Microencap-sul. 2002;19:225-35.
2. Steffansen B, Nielsen CU, Brodin B, Eriksson AH, Anderson R, Frokjaer S. Intestinal solute carriers: an overview of trends and strategies for improving oral drug absorption. Eur J Pharm Sci. 2004;21:3-16.
3. Avadi MR, Sadeghi AMM, Mohammadpour N, Abedin S, Atyabi F, Dinarvand R, et al. Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method. Nanomed-Nanotechnol. 2010;6:58-63.
4. Longer MA, Cheng HS, Robinson JR. Bioadhesive polymers as platforms for oral controlled drug delivery III: oral delivery of chlorothiazide using a bioadhesive polymer. J Pharm Sci. 1985;74:406-11.
5. Sakuma S, Hayashi M, Akashi M. Design of nanoparticles composed of graft copolymers. Adv Drug Deliv Rev. 2001;47:21-37.
6. Yin L, Ding JY, He CB, Cui LM, Tang C, Yin CH. Drug per-meability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials. 2009;30:5691-700.
7. Janes KA, Calvo P, Alonso MJ. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev. 2001;47:83-97.
8. Hassan EE, Gallo JM. A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharm Res. 1990;7:491-5.
9. Moghaddam FA, Atyabi F, Dinarvand R. Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-p HEMA core-shell nanoparticles. Nanomed-Nanotechnol. 2009;5:208-15.
10. Li YY, Chen XG, Liu CS, Cha DS, Park HJ, Lee CM. Effect of the molecular mass and degree of substitution of oleoylchitosan on the structure, rheological properties, and formation of nano-particles. J Agric Food Chem. 2007;55:4842-7.
11. Li YY, Chen XG, Yu LM, Wang SX, Sun GZ, Zhou HY. Aggregation of hydrophobically modified chitosan in solution and at the air-water interface. J Appl Polym Sci. 2006;102:1968-73.
12. Zhang J, Chen XG, Li YY, Liu CS. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin. Nanomed-Nanotechnol. 2007;3:258-65.
13. Zhang J, Chen XG, Liu CS, Hark HJ. Investigation ofpolymeric amphiphilic nanoparticles as antitumor drug carriers. J Mater Sci Mater Med. 2009;20(4):991-9.
14. Azad IS, Shankar KM, Mohan CV, Kalita B. Biofilm vaccine of Aeromonas hydrophila-standardization of dose and duration for oral vaccination of carps. Fish Shellfish Immunol. 1999;9:519-28.
15. Vivas J, Riaño J, Carracedo B, Razquin BE, López-Fierro P, Naharro G, et al. The auxotrophic aro A mutant of Aeromonas hydrophila as a live attenuated vaccine against A. salmonicida infections in rainbow trout (Oncorhynchus mykiss). Fish Shellfish Immunol. 2004;16:193-206.
16. Chen XG, Lee CM, Park HJ. O/W emulsification for the self-aggregation and nanoparticle formation of linoleic acids modified chitosan in the aqueous system. J Agric Food Chem. 2003;51:3135-9.
17. Shigemasa Y, Matsuura H, Sashiwa H, Saimoto H. Evaluation of different absorbance ratios from infrared spectroscopy for ana-lyzing the degree of deacetylation in chitin. Int J Biol Macromol. 1996;18:237-42.
18. Wan LQ, Hu FQ, Yuan H. Study of the uptake of chitosan oli-gosaccharide nanoparticles by A549 cells. Acta Pharmacol Sin. 2004;39:227-31.
19. Rodriguez LA, Ellis AE, Nieto TP. Purification and character-isation of an extracellular metalloprotease, serine protease and haemolysin of Aeromonas hydrophila strain B sub (32): all are lethal for fish. Microb Pathog. 1992;13:17-24.
20. Gan Q, Wang T. Chitosan nanoparticle as protein delivery car-rier\-systematic examination of fabrication conditions for effi-cient loading and release. Colloid Surf B. 2007;59:24-34.
21. Irie T, Watarai S, Iwasaki T, Kodama H. Protection against experimental Aeromonas salmonicida infection in carp by oral immunisation with bacterial antigen entrapped liposomes. Fish Shellfish Immunol. 2005;18:235-42.
22. Chen XG, Park HJ. Chemical characteristics of O-carboxymethyl chitosans related to the preparation conditions. Carbohyd Polym. 2003;53:355-9.
23. Xu Y, Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm. 2003;250:215-26.
24. Irie T, Watarai S, Kodama H. Humoral immune response of carp (Cyprinus carpio) induced by oral immunization with liposome-entrapped antigen. Dev Com Immunol. 2003;27:413-21.
25. Owens DR, Zinman B, Bolli G. Alternative routes of insulin delivery. Diab Med. 2003;20:886-98.
26. Khin YW, Feng SS. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials. 2005;26:2713-22.
27. Florence AT, Hillery AM, Hussain N, Jani PU. Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. J Control Release. 1995;36:39-46.
28. Robert MS, Karlo P, Fanor B, Michael L, Tarek MF. The use of deoxycholic acid to enhance the oral bioavailability of biode-gradable nanoparticles. Biomaterials. 2008;29:703-8.
29. van der Merwe SM, Verhoef JC, Verheijden JHM, Kotzé AF, Junginger HE. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm. 2004;58:225-35.
30. Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci. 1997;63:125-32.
31. Son YJ, Jang JS, Cho YW, Chung H, Park RW, Kwon IC, et al. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J Control Release. 2003;91:135-45.
32. Bravo-Osuna I, Vauthier C, Farabollini A, Palmieri GF, Ponchel G. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly (isobutyl cyanoacrylate) core-shell nanoparticles. Biomate-rials. 2007;28:2233-43.
33. Han HD, Lee A, Song CK, Hwang T, Seong H, Lee CO. In vivo distribution and antitumor activity of heparin-stabilized doxoru-bicin-loaded liposomes. Int J Pharm. 2006;313:181-8.
34. Bernkop-Schnürch A, Hornof M, Guggi D. Thiolated chitosans. Eur J Pharm Biopharm. 2004;57:9-17.
35. Schipper NGM, Olsson S, Hoogstraate JA, de Boer AG, Varum KM, Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs. 2: Mechanism of absorption enhancement. Pharm Res. 1997;14:923-9.